DOI QR코드

DOI QR Code

Urinary Levels of 8-Iso-Prostaglandin F2${\alpha}$ and 8-Hydroxydeoxyguanine as Markers of Oxidative Stress in Patients With Coronary Artery Disease

  • Kim, Jang-Young (Division of Cardiology, Department of Internal Medicine, Wonju College of Medicine, Yonsei University) ;
  • Lee, Jun-Won (Division of Cardiology, Department of Internal Medicine, Wonju College of Medicine, Yonsei University) ;
  • Youn, Young-Jin (Division of Cardiology, Department of Internal Medicine, Wonju College of Medicine, Yonsei University) ;
  • Ahn, Min-Soo (Division of Cardiology, Department of Internal Medicine, Wonju College of Medicine, Yonsei University) ;
  • Ahn, Sung-Gyun (Division of Cardiology, Department of Internal Medicine, Wonju College of Medicine, Yonsei University) ;
  • Yoo, Byung-Su (Division of Cardiology, Department of Internal Medicine, Wonju College of Medicine, Yonsei University) ;
  • Lee, Seung-Hwan (Division of Cardiology, Department of Internal Medicine, Wonju College of Medicine, Yonsei University) ;
  • Yoon, Jung-Han (Division of Cardiology, Department of Internal Medicine, Wonju College of Medicine, Yonsei University) ;
  • Choe, Kyung-Hoon (Division of Cardiology, Department of Internal Medicine, Wonju College of Medicine, Yonsei University)
  • Published : 2012.09.30

Abstract

Background and Objectives: The objective of this study was to determine if urinary levels of 8-iso-prostaglandin F2${\alpha}$ (8-iso-PGF2${\alpha}$) and 8-hydroxydeoxyguanine (8-OHdG) could be used as markers of the oxidative stress in significant coronary artery disease (CAD). Subjects and Methods: We conducted a case-control study in 104 subjects assessed by coronary angiography with the following diagnoses: 35 consecutive cases of significant CAD and 69 cases of non-CAD with stable angina. We compared the urinary levels of 8-iso-PGF 2${\alpha}$ and 8-OHdG, as measured by immunoassay between the 2 groups. Results: History of hypertension was significantly higher and high density lipoprotein-cholesterol level significantly lower in the CAD group compared with those in the non-CAD group. Median levels of 8-iso-PGF2${\alpha}$ were significantly higher in the CAD group compared with the non-CAD group (9.2 vs. 6.0 ng/mg, p=0.001). There were no significant differences in 8-OHdG values between the 2 groups. The odds ratio of 8-iso-PGF2${\alpha}$ for CAD in the highest tertile compared with that in the lowest tertile was 7.39 (95% confidence interval; 1.71- 31.91). There was no significant difference in median values of 8-iso-PGF2${\alpha}$ between single- and multi-vessel CAD. Conclusion: Urinary 8-iso-PGF 2${\alpha}$ was independently associated with significant CAD in this case-control study.

Keywords

References

  1. Schulze PC, Lee RT. Oxidative stress and atherosclerosis. Curr Atheroscler Rep 2005;7:242-8. https://doi.org/10.1007/s11883-005-0013-5
  2. Singh U, Jialal I. Oxidative stress and atherosclerosis. Pathophysiology 2006;13:129-42. https://doi.org/10.1016/j.pathophys.2006.05.002
  3. Basu S. Fatty acid oxidation and isoprostanes: oxidative strain and oxidative stress. Prostaglandins Leukot Essent Fatty Acids 2010;82: 219-25. https://doi.org/10.1016/j.plefa.2010.02.031
  4. Wang B, Pan J, Wang L, Zhu H, Yu R, Zou Y. Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease. Atherosclerosis 2006;184: 425-30. https://doi.org/10.1016/j.atherosclerosis.2005.05.008
  5. Schwedhelm E, Bartling A, Lenzen H, et al. Urinary 8-iso-prostaglandin F2alpha as a risk marker in patients with coronary heart disease: a matched case-control study. Circulation 2004;109:843-8. https://doi.org/10.1161/01.CIR.0000116761.93647.30
  6. Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics. Clin Chim Acta 2004;339:1-9. https://doi.org/10.1016/j.cccn.2003.09.010
  7. Victor VM, Rocha M, Solá E, Bañuls C, Garcia-Malpartida K, Hernández- Mijares A. Oxidative stress, endothelial dysfunction and atherosclerosis. Curr Pharm Des 2009;15:2988-3002. https://doi.org/10.2174/138161209789058093
  8. Galle J, Hansen-Hagge T, Wanner C, Seibold S. Impact of oxidized low density lipoprotein on vascular cells. Atherosclerosis 2006;185:219-26. https://doi.org/10.1016/j.atherosclerosis.2005.10.005
  9. Basu S, Risérus U, Turpeinen A, Vessby B. Conjugated linoleic acid induces lipid peroxidation in men with abdominal obesity. Clin Sci (Lond) 2000;99:511-6. https://doi.org/10.1042/CS20000116
  10. Halliwell B, Lee CY. Using isoprostanes as biomarkers of oxidative stress: some rarely considered issues. Antioxid Redox Signal 2010;13: 145-56. https://doi.org/10.1089/ars.2009.2934
  11. Montuschi P, Barnes PJ, Roberts LJ 2nd. Isoprostanes: markers and mediators of oxidative stress. FASEB J 2004;18:1791-800. https://doi.org/10.1096/fj.04-2330rev
  12. Vassalle C, Petrozzi L, Botto N, Andreassi MG, Zucchelli GC. Oxidative stress and its association with coronary artery disease and different atherogenic risk factors. J Intern Med 2004;256:308-15. https://doi.org/10.1111/j.1365-2796.2004.01373.x
  13. Mercer J, Mahmoudi M, Bennett M. DNA damage, p53, apoptosis and vascular disease. Mutat Res 2007;621:75-86. https://doi.org/10.1016/j.mrfmmm.2007.02.011
  14. Clarke MC, Littlewood TD, Figg N, et al. Chronic apoptosis of vascular smooth muscle cells accelerates atherosclerosis and promotes calcification and medial degeneration. Circ Res 2008;102:1529-38. https://doi.org/10.1161/CIRCRESAHA.108.175976
  15. Clarke MC, Figg N, Maguire JJ, et al. Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis. Nat Med 2006;12:1075-80. https://doi.org/10.1038/nm1459
  16. Jo M, Nishikawa T, Nakajima T, et al. Oxidative stress is closely associated with tumor angiogenesis of hepatocellular carcinoma. J Gastroenterol 2011;46:809-21. https://doi.org/10.1007/s00535-011-0392-z
  17. Nishikawa T, Sasahara T, Kiritoshi S, et al. Evaluation of urinary 8-hydroxydeoxy- guanosine as a novel biomarker of macrovascular complications in type 2 diabetes. Diabetes Care 2003;26:1507-12. https://doi.org/10.2337/diacare.26.5.1507
  18. Loffredo L, Pignatelli P, Cangemi R, et al. Imbalance between nitric oxide generation and oxidative stress in patients with peripheral arterial disease: effect of an antioxidant treatment. J Vasc Surg 2006;44:525-30. https://doi.org/10.1016/j.jvs.2006.05.023
  19. Kono Y, Nakamura K, Kimura H, et al. Elevated levels of oxidative DNA damage in serum and myocardium of patients with heart failure. Circ J 2006;70:1001-5. https://doi.org/10.1253/circj.70.1001

Cited by

  1. Using inflammatory and oxidative biomarkers in urine to predict early acute kidney injury in patients undergoing liver transplantation vol.19, pp.5, 2012, https://doi.org/10.3109/1354750x.2014.924997
  2. The association of serumtrans-nonachlor levels with atherosclerosis vol.79, pp.5, 2012, https://doi.org/10.1080/15287394.2016.1143901
  3. The Activity of Serum 8-Iso-Prostaglandin F2<i>α</i> as Oxidative Stress Marker in Patients with Diabetes Mellitus Type 2 and Associated Dyslipidemic Hyperglycemia vol.6, pp.4, 2012, https://doi.org/10.4236/jdm.2016.64033
  4. Association of Isoprostanes-Related Oxidative Stress with Vulnerability of Culprit Lesions in Diabetic Patients with Acute Coronary Syndrome vol.60, pp.2, 2012, https://doi.org/10.1536/ihj.18-233
  5. Urinary Biomarkers of Inflammation and Oxidative Stress Are Elevated in Obese Children and Correlate with a Marker of Endothelial Dysfunction vol.2019, pp.None, 2012, https://doi.org/10.1155/2019/9604740
  6. MicroRNA-140-5p aggravates hypertension and oxidative stress of atherosclerosis via targeting Nrf2 and Sirt2 vol.43, pp.2, 2019, https://doi.org/10.3892/ijmm.2018.3996
  7. Interdependence of Anti-Inflammatory and Antioxidant Properties of Squalene-Implication for Cardiovascular Health vol.11, pp.2, 2021, https://doi.org/10.3390/life11020103
  8. Interventional study with vitamin E in cardiovascular disease and meta-analysis vol.178, pp.None, 2022, https://doi.org/10.1016/j.freeradbiomed.2021.11.027